Showing results (121-130 of 2,406) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 11, 2022
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucroseShanlian Hu, Limin Liu, Richard F Pollock, et al.Journal of Medical Economics|March 30, 2022
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspectiveKatja C Heinz, Damon Willems, Mickaël HiligsmannJournal of Medical Economics|October 20, 2021
Economic burden to commercial payers of young adults with schizophrenia in ColoradoJacqueline Pesa, Charmi Patel, David Rotter, et al.Journal of Medical Economics|September 22, 2018
A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the USJanna Manjelievskaia, Tony B Amos, Antoine C El Khoury, et al.Journal of Medical Economics|October 11, 2018
Compliance and persistence with Alzheimer's disease treatment: a retrospective analysis of multiregional hospital databases in ThailandKhachen Kongpakwattana, Piyameth Dilokthornsakul, Charungthai Dejthevaporn, et al.Journal of Medical Economics|May 22, 2018
Clinical trials with multiple endpoints can establish a correlation, but not (yet) causality, between dietary supplementation with omega-3 fatty acids and keratoconjunctivitis siccaRoger Lee MendozaJournal of Medical Economics|June 5, 2018
Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorderArpamas Seetasith, Mallik Greene, Ann Hartry, et al.Journal of Medical Economics|September 2, 2025
Treatment patterns and outcomes in patients with lower-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents in a large US community oncology practice: a retrospective chart reviewLucio N Gordan, Gustavo Fonseca, Amanda Warner, et al.Journal of Medical Economics|September 4, 2025
Assessment of healthcare resource utilization and direct medical cost in relation to treatment length of oral corticosteroids in biologic initiated patients with ulcerative colitis: a Japanese claims database studyCeline Miyazaki, Tomoyuki Inoue, Shinya Sugimoto, et al.Journal of Medical Economics|September 6, 2025
Impact of drug utilization management strategies on the incidence and cost of clinical events in patients with non-valvular atrial fibrillation receiving DOACs in the USRupesh Subash, Elisabeth Vodicka, Serina Deeba, et al.Pageof 241